Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19052,149,0.98 [0.79-1.22],0.8676541554281868
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",20041,209,1.05 [0.87-1.25],0.633506464784608
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19807,1447,1.05 [0.98-1.12],0.1984003260799468
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Candidiasis,20055,461,1.06 [0.94-1.20],0.3360668357634276
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19396,3538,1.04 [0.99-1.08],0.1185131610093444
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19373,3593,1.01 [0.97-1.06],0.599937401951343
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19802,1187,1.04 [0.97-1.12],0.2857999696828431
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19966,111,1.08 [0.84-1.38],0.5456386248832924
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17692,1057,1.00 [0.92-1.09],0.9813131487040684
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17050,1274,1.01 [0.94-1.09],0.7761627526073072
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16690,276,1.05 [0.90-1.23],0.5259175361161099
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13080,2274,0.99 [0.94-1.05],0.704339626357863
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16642,406,1.08 [0.95-1.23],0.2197214442924441
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,20022,1407,1.03 [0.96-1.10],0.4414959776928572
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Mycoses,20128,534,1.08 [0.96-1.21],0.1984643164482233
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19378,1018,1.04 [0.96-1.13],0.339450372828688
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20067,1164,1.00 [0.92-1.08],0.9029743947844292
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18824,209,1.05 [0.87-1.26],0.6058961396074929
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20179,52,0.97 [0.67-1.39],0.8534934586531433
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19922,1019,1.00 [0.92-1.08],0.9193971783764312
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19921,66,1.08 [0.78-1.50],0.6322487632396345
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20125,113,1.20 [0.94-1.53],0.1373859925393195
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20110,98,1.23 [0.95-1.59],0.1214191159728833
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18756,396,1.06 [0.93-1.21],0.3711837563230379
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18617,257,1.04 [0.88-1.23],0.6162293322477125
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18720,105,1.07 [0.83-1.39],0.5797667495202337
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20165,48,0.85 [0.58-1.26],0.4195817145682046
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20117,154,1.18 [0.96-1.46],0.1170603524735268
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral warts,20014,51,1.66 [1.18-2.35],0.0039160210659458
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],20036,73,1.02 [0.75-1.39],0.9074590804748952
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm,19931,230,0.84 [0.70-1.00],0.0543117124823016
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20104,39,0.93 [0.61-1.43],0.75224427308418
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20091,41,1.01 [0.67-1.53],0.9452291147069886
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9551,72,0.77 [0.56-1.06],0.1135047183259669
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19778,1450,1.00 [0.93-1.07],0.91391076900562
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of meninges,20165,57,1.26 [0.89-1.77],0.1888698439558728
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20096,72,1.08 [0.79-1.47],0.6400339577397935
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20155,102,0.98 [0.76-1.27],0.8849745334859853
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of ovary,10576,65,1.13 [0.82-1.55],0.4628650267825216
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20144,393,0.98 [0.86-1.12],0.7724053581314319
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Caecum,20156,334,0.99 [0.86-1.15],0.9101797349196118
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20052,76,0.78 [0.57-1.06],0.1119593080108876
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Descending colon,20143,223,0.97 [0.81-1.16],0.7376293517677446
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Rectum,20100,354,0.98 [0.85-1.13],0.7916768378239512
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,20040,608,1.05 [0.95-1.17],0.3417777344815584
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20134,462,1.02 [0.90-1.15],0.7807458421819329
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Carcinoma in situ of breast,7955,44,0.88 [0.59-1.32],0.5437716631756767
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7988,54,1.10 [0.77-1.58],0.5859292005611915
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14451,64,0.88 [0.63-1.23],0.4582181775245764
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14471,84,0.87 [0.64-1.17],0.346939584106501
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20126,110,0.80 [0.62-1.04],0.0952228592925982
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Haemangioma, any site",20127,107,0.82 [0.63-1.06],0.132411990441912
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Leiomyoma of uterus,10335,147,1.02 [0.82-1.27],0.8326400011372441
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Lung cancer and mesothelioma,12867,436,0.97 [0.85-1.10],0.6150259626688657
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Lymphoid leukaemia,14452,65,0.93 [0.67-1.31],0.692108988760125
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14577,190,1.10 [0.91-1.33],0.3425970522136514
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14649,262,0.96 [0.81-1.13],0.6148949862041567
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",8070,98,0.81 [0.61-1.06],0.128669909702429
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14485,98,1.18 [0.90-1.53],0.2233203707676556
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14511,124,1.11 [0.87-1.40],0.3956581817183774
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14499,112,0.86 [0.67-1.12],0.260580227013348
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8052,80,0.96 [0.71-1.30],0.8039405634312058
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14497,110,0.94 [0.72-1.21],0.6150012622989431
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7238,823,0.90 [0.82-0.99],0.0238312270167347
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14502,115,0.84 [0.65-1.09],0.1841180350651675
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14471,84,1.15 [0.86-1.53],0.3457817661539093
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14510,123,1.01 [0.79-1.28],0.95705074592196
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanocytic naevi,20051,162,1.10 [0.90-1.35],0.3613880717876144
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanocytic naevi of trunk,20154,68,1.18 [0.86-1.62],0.3010826618226979
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanoma in situ,14434,100,1.04 [0.79-1.35],0.7888622699554022
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14492,105,0.89 [0.68-1.16],0.3943383247232057
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14561,174,0.95 [0.77-1.16],0.6229909054381512
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14689,302,0.83 [0.71-0.97],0.0193956130307811
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14500,113,1.06 [0.82-1.36],0.6625269212519647
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Other benign neoplasms of skin,20031,147,0.91 [0.73-1.13],0.3791236335957435
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15670,1283,0.96 [0.89-1.04],0.3275041445061351
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15738,1351,0.98 [0.91-1.05],0.5352521228935891
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19914,334,0.95 [0.82-1.10],0.4717687823705403
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18223,112,1.11 [0.87-1.43],0.3993227549835645
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19641,61,1.17 [0.84-1.63],0.3671551742188991
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19551,2964,1.06 [1.01-1.11],0.0284952724920513
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18739,62,1.83 [1.34-2.50],0.0001567024150854
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19784,60,0.96 [0.68-1.36],0.8294469304763397
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19766,1655,1.05 [0.99-1.12],0.1080451061538994
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19764,1653,1.05 [0.99-1.12],0.1192030898379587
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18209,98,0.86 [0.65-1.13],0.2734043140089909
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19871,1194,1.22 [1.13-1.31],2.635922006449172e-07
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19824,100,0.92 [0.70-1.20],0.5249889896749598
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19641,61,0.83 [0.58-1.17],0.2825958175175217
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19651,71,1.05 [0.77-1.43],0.7716461138699411
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,20021,297,0.73 [0.62-0.85],9.149173868228106e-05
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20070,33,0.70 [0.43-1.13],0.1445683338109618
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19965,241,0.58 [0.49-0.70],5.736139462812309e-09
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18791,114,1.04 [0.81-1.33],0.7806842356329717
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13653,339,0.97 [0.84-1.13],0.7264229958985852
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18879,86,1.20 [0.89-1.62],0.2238092068887242
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18887,94,1.16 [0.88-1.52],0.2848391192079387
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13377,63,0.98 [0.70-1.37],0.9143648969620788
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18793,44,0.87 [0.59-1.31],0.5121821008247069
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18149,268,0.87 [0.74-1.03],0.1069265932444955
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19525,766,0.90 [0.81-0.99],0.0297855039127737
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19175,416,0.89 [0.78-1.02],0.0875663741476725
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18906,147,1.06 [0.85-1.32],0.6025532771269144
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19951,1202,1.09 [1.01-1.17],0.0248717420135998
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17082,1172,1.11 [1.02-1.19],0.0101040203497515
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13387,73,0.85 [0.62-1.17],0.3193274163999447
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",18227,86,1.16 [0.88-1.54],0.2899883518199205
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13623,309,1.04 [0.89-1.20],0.6475908843857923
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13364,50,0.90 [0.62-1.31],0.5892430102479038
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17244,3930,1.03 [0.99-1.07],0.1862006340596569
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13545,231,0.95 [0.80-1.13],0.5703689994825336
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13918,604,1.01 [0.91-1.13],0.8391936107200029
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20130,312,1.08 [0.93-1.25],0.2997485395564749
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19944,126,0.87 [0.69-1.11],0.2603406286012676
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13442,128,1.05 [0.83-1.32],0.6936868553740894
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13383,69,0.97 [0.70-1.33],0.8309872495973103
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19632,1491,1.00 [0.93-1.07],0.976110781566498
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13633,319,1.03 [0.88-1.19],0.7421323128520587
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13643,329,0.88 [0.76-1.02],0.0828850048006297
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14054,740,1.07 [0.97-1.18],0.1838052840058882
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13444,130,0.77 [0.61-0.98],0.0365246840883189
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19938,120,0.86 [0.67-1.10],0.2362213408016667
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14082,768,1.01 [0.92-1.11],0.8233580347321312
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13870,556,0.97 [0.87-1.08],0.5915441125700736
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17941,60,1.03 [0.74-1.44],0.8619922431146774
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18835,5521,1.01 [0.98-1.05],0.4449606004494756
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,18192,51,0.97 [0.67-1.40],0.8541699830498871
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,18188,47,0.96 [0.65-1.41],0.8240241441637016
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20028,1601,0.95 [0.89-1.02],0.1450297852565987
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20026,1599,0.96 [0.89-1.02],0.1758777066452056
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,18196,55,1.08 [0.76-1.53],0.6714911458561681
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19874,985,1.04 [0.96-1.13],0.3462124828111002
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15196,1882,0.99 [0.93-1.05],0.710469971553316
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20168,251,0.92 [0.78-1.09],0.3595821447160046
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18856,97,0.94 [0.71-1.23],0.6293850720416012
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18991,102,1.00 [0.77-1.30],0.9755078827307764
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19034,145,1.18 [0.95-1.46],0.1384717476848355
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13480,166,1.01 [0.82-1.24],0.9336367159790931
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17770,155,0.90 [0.73-1.11],0.3206280442009543
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2148,83,1.04 [0.77-1.41],0.7909893617908728
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2287,256,0.99 [0.84-1.17],0.9240076681465684
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17683,68,1.15 [0.84-1.58],0.3807386107278475
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2116,52,0.82 [0.56-1.21],0.3270565724890274
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19470,1855,1.00 [0.94-1.07],0.8938418435217621
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19269,510,0.85 [0.75-0.96],0.0084896773686045
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18255,374,1.01 [0.88-1.15],0.936482829391036
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14233,919,1.00 [0.92-1.09],0.9790782616823092
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20061,265,0.76 [0.64-0.90],0.0011650164317154
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18919,233,0.89 [0.75-1.07],0.2120482538062076
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Angina pectoris,17491,1317,1.01 [0.94-1.08],0.8215021685682296
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19008,322,0.87 [0.75-1.01],0.0594427989112086
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18756,70,0.91 [0.66-1.25],0.5612072895695593
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18922,236,1.09 [0.92-1.29],0.3091724064424682
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10293,2415,0.94 [0.89-1.00],0.0336873546350833
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,AV-block,15450,565,0.98 [0.88-1.10],0.7639109897485028
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20107,478,0.90 [0.80-1.02],0.1006979017156292
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cardiac arrest,8105,227,1.14 [0.96-1.35],0.1459024997503134
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15060,175,0.75 [0.61-0.92],0.0062609033744612
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14974,89,0.88 [0.66-1.17],0.3711404096935035
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20173,60,1.20 [0.85-1.68],0.2927376867113146
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Conduction disorders,16200,1315,0.98 [0.91-1.06],0.6759910129845328
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18517,2365,1.00 [0.94-1.05],0.9355098748712825
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16337,7757,1.00 [0.97-1.03],0.8513694970196212
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18831,291,0.78 [0.66-0.91],0.0020167073796169
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Endocarditis,14962,77,1.08 [0.80-1.46],0.6031729912996393
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19935,1407,1.05 [0.97-1.12],0.2107689178357434
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypertension,17404,6863,1.01 [0.98-1.04],0.5842095812673298
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17408,6867,1.01 [0.98-1.04],0.5959432082614139
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, portal",20032,87,0.84 [0.63-1.12],0.2299001261061509
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10785,244,1.06 [0.90-1.26],0.4641781340649191
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10670,129,1.12 [0.89-1.41],0.3262693614047471
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypotension,20022,1339,1.01 [0.94-1.08],0.8377104244559533
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19088,125,0.86 [0.68-1.10],0.2381225564614285
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18667,2493,1.02 [0.96-1.07],0.5519377045739307
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19748,678,1.04 [0.94-1.16],0.4028656377867329
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15318,433,0.95 [0.84-1.08],0.4450278058513615
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19613,910,1.02 [0.94-1.12],0.5922628124219762
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16954,780,1.06 [0.96-1.16],0.2379664996563016
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20066,167,1.27 [1.04-1.55],0.0177553882246975
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20139,347,0.98 [0.85-1.13],0.8112137995898531
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Oesophageal varices,18600,60,0.96 [0.68-1.35],0.8008781962242673
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other aneurysm,18773,87,1.07 [0.80-1.41],0.6542648721951356
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other arrhythmias,15392,507,1.06 [0.94-1.19],0.3295560953903486
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18799,113,0.97 [0.76-1.25],0.8303118280705524
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18964,278,0.98 [0.84-1.15],0.8096507080439692
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15078,193,1.07 [0.88-1.29],0.4868632191197946
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other disorders of veins,18630,90,1.20 [0.91-1.58],0.1888356146676026
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18579,39,1.08 [0.71-1.64],0.724220601266503
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18456,75,0.92 [0.67-1.25],0.5971746673294309
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18685,145,0.96 [0.77-1.20],0.7344698410356874
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16093,1208,0.96 [0.89-1.04],0.3175907383434618
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18735,52,0.89 [0.62-1.30],0.5554074516654666
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19295,609,0.99 [0.89-1.10],0.8621076723312059
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19516,474,1.02 [0.90-1.15],0.732522790503335
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19195,814,1.00 [0.91-1.10],0.9669893509779456
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8231,353,0.97 [0.84-1.12],0.6681505639113927
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19145,491,1.02 [0.91-1.15],0.7070677845465474
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18904,364,0.79 [0.68-0.91],0.001010319690887
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19551,509,0.92 [0.82-1.03],0.1601612602538624
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20088,816,0.98 [0.90-1.08],0.7078874473813377
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15328,443,1.01 [0.89-1.14],0.904528459615358
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19511,469,1.02 [0.91-1.16],0.6986513753822909
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18600,219,0.98 [0.82-1.17],0.8264901470370457
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19733,770,1.03 [0.94-1.13],0.5586351619594454
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19721,803,1.03 [0.94-1.13],0.5252386299202965
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19060,51,0.95 [0.66-1.38],0.7971229840891717
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18769,83,0.83 [0.62-1.12],0.2281489848959944
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19340,270,1.09 [0.93-1.28],0.2845949524796164
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18987,284,1.00 [0.86-1.17],0.9786232185025444
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Varicose veins,18979,439,1.08 [0.95-1.22],0.2330856263061687
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18701,98,0.92 [0.71-1.21],0.5547439201641177
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19934,804,0.87 [0.79-0.95],0.0027447000597434
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20108,290,1.07 [0.92-1.25],0.400344609697577
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17347,1197,1.05 [0.97-1.13],0.1918968460381297
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Any mental disorder,19733,3583,1.03 [0.99-1.08],0.1591331947352191
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",20083,340,1.05 [0.91-1.21],0.5226336347143135
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17373,1223,1.10 [1.02-1.18],0.0136012359604501
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16215,65,1.01 [0.73-1.40],0.9648917059917516
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Smoking dependency,19737,1005,1.07 [0.99-1.16],0.0933347160177252
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17396,1246,1.05 [0.98-1.13],0.1820310007709932
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Vascular dementia,19458,200,0.88 [0.73-1.07],0.2075715677201047
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Alzheimer disease,20176,510,0.92 [0.82-1.04],0.1677512638731946
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12579,95,0.95 [0.72-1.25],0.7045116138169545
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Bell's palsy,18594,73,1.21 [0.90-1.64],0.2122236159458434
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18949,428,1.08 [0.95-1.22],0.257128010436683
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Cerebral cysts,19803,208,0.95 [0.79-1.15],0.604619067334663
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20113,330,0.91 [0.78-1.05],0.1850141422119213
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19471,71,1.06 [0.78-1.45],0.6990266189844685
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20159,63,0.87 [0.62-1.22],0.4190980114298752
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19663,68,1.02 [0.74-1.41],0.9120693865310489
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Epilepsy,18904,253,0.91 [0.77-1.08],0.2655472805976136
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19785,1134,1.00 [0.92-1.08],0.9101383673568618
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20128,547,0.95 [0.84-1.06],0.337329516399119
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19607,2878,0.95 [0.90-1.00],0.0418037036382059
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Generalized epilepsy,19861,45,1.19 [0.81-1.75],0.3845322859464223
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Hemiplegia,20053,270,1.00 [0.85-1.17],0.9733383813309304
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Hydrocephalus,19657,62,0.86 [0.61-1.21],0.3908743278629607
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20164,58,1.13 [0.80-1.60],0.4777775179354451
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18584,63,0.85 [0.60-1.19],0.3335474804279074
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18583,62,0.98 [0.70-1.38],0.9146234920108708
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Memory loss,19241,133,0.93 [0.74-1.17],0.5249374635382127
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Migraine,18888,237,0.99 [0.83-1.17],0.8827825454825169
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20133,216,0.98 [0.82-1.18],0.8411480145629805
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Motor neuron disease,12674,168,0.96 [0.78-1.18],0.7010912051189357
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20067,52,1.00 [0.70-1.44],0.9798454605123096
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19569,1048,1.05 [0.97-1.14],0.2094561067289849
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Neurological diseases,18904,3578,0.99 [0.95-1.03],0.6462955659086012
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19644,244,1.00 [0.84-1.18],0.9563421946868452
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18866,345,1.08 [0.94-1.25],0.2657096971304705
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20108,292,1.05 [0.90-1.22],0.5716481165627101
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15307,815,0.97 [0.88-1.07],0.5277049331494374
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19665,70,0.88 [0.64-1.21],0.4137984981012154
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19728,133,0.85 [0.68-1.08],0.1844125787261066
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19763,182,1.08 [0.89-1.31],0.4291963302964894
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18601,80,1.17 [0.87-1.56],0.3002924437614421
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other headache syndromes,18696,45,0.92 [0.62-1.37],0.6862694659016619
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other neurological diseases,20082,487,0.95 [0.85-1.08],0.4534823009896689
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other sleep disorders,19080,429,0.99 [0.87-1.12],0.8431184447365424
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Parkinson's disease,20145,345,0.90 [0.78-1.04],0.1614166818262088
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19635,40,0.97 [0.64-1.48],0.8942204244256663
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Restless leg syndrome,20175,79,0.92 [0.68-1.24],0.5889556682003958
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Sleep apnoea,19988,371,1.01 [0.88-1.16],0.9243728952077958
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19868,52,1.00 [0.69-1.44],0.9957459317368704
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20164,189,0.94 [0.77-1.14],0.520039537595125
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18584,63,1.11 [0.80-1.54],0.5422380764776702
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20176,515,0.92 [0.82-1.04],0.1666213173343079
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19403,194,0.87 [0.72-1.06],0.1737711584077234
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19630,131,1.00 [0.79-1.25],0.9730543671441938
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19800,486,0.99 [0.88-1.12],0.8799887165311578
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19971,225,0.92 [0.77-1.10],0.33973592908732
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19111,59,1.05 [0.74-1.48],0.7977959485640105
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19087,35,1.87 [1.24-2.84],0.0031044618045746
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20070,65,1.28 [0.93-1.75],0.1351867734137568
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19901,194,1.01 [0.84-1.22],0.9115025962885216
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2120,55,0.78 [0.53-1.13],0.1868747534442479
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2603,94,0.99 [0.74-1.31],0.9187994591502422
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19593,94,1.12 [0.86-1.47],0.3940905726755132
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19941,1224,1.04 [0.96-1.12],0.323044537714377
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19816,764,1.07 [0.97-1.18],0.1582936700597014
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19311,259,1.20 [1.02-1.41],0.0295530937190059
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20121,807,0.99 [0.90-1.09],0.8384119195487607
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20170,69,1.43 [1.06-1.93],0.0208530692031657
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20067,753,0.98 [0.89-1.08],0.6995302984190929
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20141,434,0.98 [0.86-1.11],0.729168075808899
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20070,193,1.08 [0.89-1.31],0.4181682284241873
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19143,91,1.30 [0.99-1.71],0.0575174703532413
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19143,91,0.96 [0.72-1.27],0.7575710840025162
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19118,66,1.26 [0.92-1.74],0.1547227264318471
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20058,870,1.01 [0.92-1.10],0.9019139268619216
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19427,239,0.96 [0.81-1.14],0.6287977437792677
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19374,60,0.78 [0.55-1.11],0.1703728545112875
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19817,110,0.88 [0.68-1.13],0.3130894955969063
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,20043,336,0.98 [0.85-1.13],0.7588403955515939
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19501,187,0.97 [0.80-1.17],0.7202684970278892
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19997,120,0.92 [0.72-1.18],0.5224579213506247
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19755,567,1.02 [0.91-1.14],0.7376604283344222
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19637,138,0.92 [0.73-1.16],0.4810690214918047
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18072,2800,1.02 [0.97-1.07],0.5293139011618716
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,20005,298,0.97 [0.83-1.13],0.701337969246749
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20161,162,1.03 [0.84-1.26],0.7940370276757829
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19525,473,1.02 [0.90-1.15],0.8011550088822919
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19788,81,0.89 [0.66-1.20],0.461062378273083
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20162,61,1.43 [1.04-1.98],0.0288019247206487
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19161,109,0.87 [0.67-1.13],0.292117452736669
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19207,155,0.90 [0.73-1.12],0.3460979035529595
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18857,140,1.23 [0.99-1.53],0.0618708193162776
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19362,48,0.82 [0.56-1.21],0.3240553191546543
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18784,67,0.62 [0.44-0.88],0.0066405464636044
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19289,101,0.87 [0.67-1.14],0.3102864959321636
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19434,246,1.06 [0.89-1.25],0.5143212629531961
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19186,134,1.08 [0.86-1.35],0.5206850163008745
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18799,82,1.18 [0.88-1.57],0.267151289437084
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18823,106,1.06 [0.82-1.37],0.638206176297482
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17603,2331,1.01 [0.95-1.06],0.8189010543604041
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19134,82,1.43 [1.08-1.90],0.0126998371428872
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19932,433,1.02 [0.90-1.16],0.7642431041498203
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19567,68,1.10 [0.80-1.51],0.567879757001903
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19664,165,0.98 [0.80-1.21],0.879009111610912
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19973,99,0.88 [0.67-1.15],0.3415340871397025
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20139,119,0.98 [0.77-1.25],0.8571283753249425
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20060,98,1.18 [0.91-1.53],0.2233933600214447
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19933,59,1.03 [0.73-1.46],0.8488819443777962
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19936,62,0.97 [0.69-1.36],0.8572833164076857
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20079,1027,1.02 [0.94-1.10],0.6979952884783682
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19832,780,1.04 [0.95-1.14],0.418612114201174
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19176,124,0.73 [0.57-0.94],0.0141578319220524
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19129,77,1.15 [0.86-1.55],0.3469580907607581
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute pharyngitis,20003,55,0.96 [0.67-1.38],0.8456984162165391
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20107,159,0.95 [0.77-1.18],0.6573741754918864
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,20001,53,0.90 [0.62-1.29],0.5535821894006558
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,All influenza,17914,130,1.03 [0.82-1.30],0.7991397211183299
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17911,127,1.06 [0.84-1.34],0.6271730174683401
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12516,85,1.38 [1.04-1.83],0.0235666483682684
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Allergic rhinitis,20089,204,1.10 [0.92-1.32],0.3109274785231874
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13621,1513,1.08 [1.01-1.16],0.0231401239970091
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13926,1495,1.07 [1.00-1.15],0.0489858819902812
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19728,154,1.18 [0.96-1.46],0.1161444954383695
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17871,87,1.18 [0.89-1.56],0.2518980228591468
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Bronchiectasis,16901,448,1.22 [1.08-1.38],0.0015244018413944
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16517,64,1.41 [1.03-1.94],0.0334572797190248
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19200,2747,1.08 [1.03-1.14],0.0024589679778216
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19114,65,1.11 [0.81-1.54],0.5126388004415119
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Chronic sinusitis,19164,115,1.06 [0.83-1.35],0.6587526822312182
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19922,1394,1.07 [1.00-1.15],0.0472791774549104
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Deviated nasal septum,19121,72,1.10 [0.81-1.49],0.5602337661494448
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18308,5255,1.04 [1.00-1.08],0.0280165787393945
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19350,301,1.06 [0.91-1.23],0.4782356897509484
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Early onset COPD,18629,101,0.94 [0.73-1.23],0.6662413378312246
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Emphysema,16834,381,1.13 [0.99-1.29],0.0792344887111316
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19023,414,1.05 [0.92-1.19],0.4777142168571643
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19947,2163,1.04 [0.98-1.10],0.1733892114128477
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Interstitial lung disease,19060,451,1.08 [0.95-1.22],0.2280938632670257
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Later onset COPD,19709,1293,1.08 [1.01-1.17],0.0282733969228171
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20160,393,1.12 [0.98-1.28],0.0883980311687343
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Nasal polyp,19136,87,1.06 [0.79-1.40],0.706265525910786
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19928,1093,1.01 [0.93-1.10],0.7834597179130778
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other diseases of pleura,19927,2305,1.04 [0.99-1.10],0.1535744963318576
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19704,655,1.08 [0.97-1.19],0.1541704863446503
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other pleural conditions,17677,55,0.77 [0.53-1.11],0.1604480577880269
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20060,531,1.07 [0.96-1.20],0.2305989583282074
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20062,1485,1.06 [0.99-1.13],0.1223454070280934
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pleural effusion,18761,1139,1.02 [0.94-1.10],0.7059838798596209
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pleural plaque,17848,226,1.00 [0.84-1.20],0.9697014456484402
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19704,1920,1.03 [0.97-1.10],0.2920206386408542
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20061,294,1.14 [0.98-1.33],0.0855416092064139
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pneumothorax,17774,152,0.86 [0.69-1.06],0.1624586685504791
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pollen allergy,20168,171,1.17 [0.96-1.43],0.1195718424877216
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pulmonary oedema,19607,78,0.89 [0.66-1.21],0.4615420277595738
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12493,62,1.33 [0.96-1.85],0.0850884854421162
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19912,1077,1.01 [0.93-1.09],0.8235800807010312
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19254,205,1.10 [0.92-1.32],0.2921949026172512
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Viral pneumonia,18032,248,1.03 [0.87-1.22],0.707788418411569
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19738,197,1.00 [0.83-1.21],0.9798284556409188
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6513,105,1.08 [0.83-1.40],0.5627583079110146
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12906,50,1.09 [0.75-1.58],0.6570933821183096
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute appendicitis,20073,110,0.95 [0.73-1.22],0.6691044157325896
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute gastritis,14104,86,1.15 [0.87-1.52],0.3316587998174538
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute pancreatitis,18429,167,1.12 [0.91-1.37],0.2906192084733361
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute peritonitis,19759,91,1.16 [0.88-1.53],0.282873376699944
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19329,52,0.82 [0.56-1.20],0.3119914277420076
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Barrett oesophagus,14452,434,0.97 [0.86-1.11],0.6781433617029244
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18389,127,1.19 [0.95-1.50],0.1300741817164357
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19814,127,1.19 [0.95-1.50],0.1309963191071711
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Cholecystitis,18448,186,0.88 [0.72-1.07],0.2112405050632971
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Cholelithiasis,19166,904,1.03 [0.94-1.12],0.5009778356257847
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Chronic gastritis,14313,295,1.05 [0.90-1.23],0.5215628783816455
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18308,46,1.06 [0.72-1.57],0.7583598081735963
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20056,111,0.92 [0.71-1.19],0.5222822051906584
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Coeliac disease,18688,104,1.13 [0.88-1.46],0.3315765664790048
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Collagenous colitis,18659,87,0.90 [0.68-1.20],0.4915727992189177
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20075,143,1.02 [0.81-1.27],0.8882999314112715
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Constipation,19931,1784,0.97 [0.91-1.04],0.3964600579556587
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Crohn disease,18643,71,1.16 [0.85-1.58],0.3617659345036726
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19870,55,1.13 [0.79-1.60],0.5113517703627701
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18636,64,1.15 [0.83-1.59],0.4138331951788414
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Dental caries,19635,163,1.02 [0.83-1.25],0.8836087380398818
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17469,2209,0.99 [0.94-1.05],0.7527303706724805
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of appendix,20099,136,0.98 [0.78-1.23],0.881747211659983
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of liver,20074,797,0.95 [0.86-1.04],0.2838573963921231
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17979,3961,1.02 [0.98-1.06],0.3387347544041388
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19881,409,0.99 [0.86-1.12],0.8222165347206604
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20100,432,1.01 [0.89-1.14],0.9152394659129958
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19552,80,0.91 [0.67-1.22],0.5262411723279901
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19446,48,1.07 [0.73-1.56],0.7318615592515305
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19898,1314,0.98 [0.91-1.05],0.5867591448623122
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of tongue,19454,81,1.05 [0.79-1.41],0.724585990960578
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19573,1311,1.05 [0.98-1.13],0.1770244217304863
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16142,3286,0.99 [0.95-1.04],0.7627241587067451
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Duodenal ulcer,14226,208,1.00 [0.83-1.20],0.9919396100641932
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20088,168,1.05 [0.85-1.28],0.6524841549798763
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20148,20,1.29 [0.73-2.30],0.3801037963249126
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19406,129,0.92 [0.73-1.17],0.5123565848003709
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12951,95,1.16 [0.89-1.52],0.2789474995715888
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Functional dyspepsia,14501,483,1.09 [0.97-1.22],0.166959528756481
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastric ulcer,14382,364,1.09 [0.95-1.25],0.2211764446064569
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16314,2296,1.01 [0.96-1.07],0.6550518220959736
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14569,551,1.05 [0.94-1.17],0.4196622322483559
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14643,7135,1.01 [0.98-1.04],0.4900094442477148
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,GI-bleeding,19666,1082,0.97 [0.89-1.05],0.4589295676918534
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19517,45,0.91 [0.61-1.36],0.6439302600049752
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13716,1027,0.93 [0.86-1.01],0.0917544859177367
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19336,59,0.78 [0.55-1.11],0.1710980075330897
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Hernia,18395,3135,1.01 [0.96-1.06],0.6904872861855652
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Impacted teeth,20150,19,1.41 [0.79-2.53],0.2500067581416234
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Impaction of intestines,12921,65,0.81 [0.57-1.13],0.2134956134835932
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Inguinal hernia,16207,947,1.03 [0.95-1.12],0.4691629339697402
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15363,103,1.09 [0.84-1.41],0.5241975667290337
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12955,99,0.95 [0.72-1.24],0.7005878213315184
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18707,123,1.02 [0.80-1.29],0.8925038010571454
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13293,437,1.00 [0.88-1.13],0.9574728375058776
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20153,284,1.04 [0.89-1.21],0.660553325134959
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19249,677,1.05 [0.95-1.17],0.3110576305496106
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19515,943,1.02 [0.94-1.11],0.6180912961193024
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oesophageal obstruction,14205,187,0.84 [0.69-1.02],0.0776618493007238
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oesophagitis,14629,611,1.05 [0.94-1.17],0.3753952157653719
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20126,119,1.13 [0.89-1.43],0.3318601636930141
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15330,70,1.03 [0.75-1.42],0.838088691179375
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14047,1191,1.02 [0.95-1.10],0.5608044866870592
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18568,306,1.08 [0.93-1.25],0.3118358957094217
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18387,125,0.94 [0.74-1.19],0.6174175175521812
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of intestine,14526,1670,0.95 [0.89-1.01],0.1241965293256752
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of intestines,18179,5323,0.97 [0.94-1.01],0.1633151741612164
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19425,188,1.15 [0.95-1.39],0.150214170686913
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of liver,19936,659,0.94 [0.85-1.04],0.2410912808008358
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14686,668,0.97 [0.87-1.07],0.53460468197929
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18441,179,0.92 [0.76-1.13],0.435111348639664
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20036,368,0.98 [0.85-1.12],0.758824735821809
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14964,946,1.01 [0.92-1.10],0.885664182273379
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19678,1094,0.97 [0.89-1.05],0.4251994027112176
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19625,153,0.91 [0.74-1.13],0.4165093157203535
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14679,1823,0.97 [0.91-1.03],0.2665828131562268
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15894,1876,0.97 [0.91-1.03],0.2722856896204232
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19377,100,0.96 [0.74-1.26],0.7822455529460559
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19406,834,1.01 [0.92-1.11],0.8194748945652753
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13233,377,0.97 [0.84-1.11],0.6551090874272554
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20145,24,1.48 [0.88-2.48],0.1374523759500902
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13381,525,0.95 [0.84-1.07],0.3861010667726361
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18726,142,1.03 [0.82-1.28],0.8233219416813966
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20164,45,0.62 [0.41-0.94],0.0246762765430631
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19467,88,0.90 [0.67-1.19],0.4521211626969472
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Toxic colitis,18643,71,0.90 [0.65-1.24],0.5096621246470574
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14320,302,1.08 [0.93-1.26],0.3232369732474995
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ulcerative colitis,18717,145,1.08 [0.86-1.34],0.515075306739965
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18689,117,1.09 [0.85-1.39],0.4902935299057318
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Umbilical hernia,15484,224,0.98 [0.82-1.18],0.8655379660720486
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,13064,208,0.92 [0.76-1.11],0.3658735489275824
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ventral hernia,15492,232,1.03 [0.87-1.23],0.7132833337399287
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Volvulus,12933,77,0.77 [0.56-1.06],0.1050163727976033
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20087,358,1.02 [0.89-1.18],0.7411502997277644
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19861,62,1.20 [0.86-1.67],0.2765612848970606
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18000,145,0.91 [0.73-1.14],0.4184601108617213
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19639,713,0.96 [0.87-1.06],0.4523597878023283
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19051,125,1.00 [0.79-1.27],0.9915396875739132
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18367,512,0.91 [0.80-1.02],0.1044538095419811
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19872,274,1.03 [0.88-1.21],0.6796497289379244
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20079,481,0.99 [0.88-1.12],0.9319962792080744
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19642,44,0.95 [0.64-1.43],0.8173383399494395
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18788,3206,0.96 [0.91-1.00],0.0704371851125186
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19797,373,0.91 [0.79-1.05],0.1911422379156619
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19682,258,0.90 [0.77-1.07],0.2369976541145602
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19848,922,0.95 [0.87-1.04],0.2607773493433375
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20159,51,0.82 [0.56-1.19],0.2952456404806294
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17911,56,0.94 [0.66-1.34],0.729060365690178
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19478,54,0.89 [0.62-1.28],0.5336870377542544
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19860,262,1.02 [0.86-1.20],0.8384782448770506
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18373,518,0.95 [0.84-1.07],0.3851472667207641
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17936,81,0.84 [0.62-1.13],0.2537192724609182
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20103,74,0.73 [0.53-1.00],0.0535836142682985
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19112,186,1.05 [0.87-1.28],0.5947859664352122
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19997,198,1.01 [0.84-1.21],0.9360347280542616
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19676,78,0.99 [0.73-1.33],0.9301702491759396
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17919,64,0.82 [0.58-1.15],0.2429647750172512
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19645,1790,0.96 [0.90-1.02],0.1897535849405961
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18410,555,0.94 [0.84-1.06],0.3037364220443549
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17939,84,0.82 [0.61-1.10],0.1906813327171458
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20097,298,1.02 [0.87-1.18],0.8318130989904404
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19664,66,0.95 [0.68-1.32],0.7494074641507957
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,20045,246,1.06 [0.89-1.25],0.519955411890954
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20115,386,1.00 [0.87-1.14],0.9505703088574392
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17964,109,0.88 [0.68-1.14],0.3279908178497737
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18143,288,0.87 [0.75-1.03],0.098334184376838
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20103,374,1.00 [0.87-1.15],0.9680924401982786
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18131,276,1.02 [0.87-1.20],0.8168560799425528
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20152,123,0.83 [0.65-1.05],0.1245969140434705
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16834,70,0.90 [0.66-1.24],0.5293524021735083
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17798,5558,1.03 [1.00-1.07],0.0769389311895771
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16573,4333,1.03 [0.99-1.07],0.1601422203081697
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16810,46,1.03 [0.70-1.52],0.8752329655863595
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16806,120,1.05 [0.82-1.33],0.7119496236001953
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16848,162,0.93 [0.75-1.14],0.477969275796979
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19957,53,0.80 [0.55-1.16],0.2409199613775746
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16813,127,0.96 [0.76-1.22],0.7564542979482258
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13521,1281,1.05 [0.97-1.13],0.2071947900012836
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19987,213,0.99 [0.83-1.19],0.9146491696033544
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17173,487,1.10 [0.98-1.24],0.1159354830903175
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16349,6964,1.02 [0.99-1.06],0.156839510059922
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,18008,109,0.91 [0.70-1.17],0.4518851221588835
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16918,154,1.03 [0.83-1.27],0.8072315236689832
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17209,445,1.01 [0.89-1.14],0.9347985632305044
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19359,2673,1.02 [0.97-1.07],0.5335633612575137
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17036,272,0.79 [0.67-0.93],0.0057006051364117
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16890,126,1.27 [1.01-1.59],0.0424152118129227
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16869,105,0.99 [0.76-1.28],0.915714174249868
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19503,87,1.02 [0.77-1.36],0.8768091474587238
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13972,1732,1.03 [0.97-1.10],0.3766907141965382
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12902,662,1.15 [1.04-1.27],0.0083675510856
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20090,656,1.13 [1.02-1.25],0.0237713486829185
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12304,64,1.11 [0.80-1.54],0.546976439392957
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12507,267,0.94 [0.79-1.10],0.4244976484839405
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16991,227,1.00 [0.84-1.19],0.9880446128882002
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12655,415,1.00 [0.88-1.15],0.942569721742058
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16756,70,1.49 [1.11-2.02],0.0090514566994871
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17259,573,1.01 [0.90-1.12],0.8942085397951902
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16947,261,1.07 [0.91-1.26],0.4081357026336164
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12629,389,1.01 [0.88-1.16],0.8939372795413103
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16824,60,1.13 [0.81-1.58],0.48530550685953
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16812,48,1.19 [0.82-1.73],0.3596935085726102
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17969,70,1.03 [0.75-1.41],0.8768861543849422
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19809,1910,0.96 [0.91-1.02],0.2271886867262883
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19245,1346,0.95 [0.88-1.02],0.1560368908520687
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20033,471,1.12 [1.00-1.27],0.0600392578116871
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14939,2699,1.05 [1.00-1.11],0.0466649524166386
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12279,39,0.90 [0.59-1.39],0.637836535855044
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16852,88,0.99 [0.75-1.31],0.9379259404996352
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12306,66,1.16 [0.84-1.61],0.3696447040634903
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12358,118,0.99 [0.78-1.27],0.947274199142003
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,18105,206,0.93 [0.77-1.12],0.436295808068627
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,18320,421,0.95 [0.84-1.08],0.4524752795111966
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20159,93,1.38 [1.06-1.79],0.0175642007084982
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18367,1681,1.01 [0.94-1.07],0.8475646468909379
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16825,61,1.56 [1.13-2.15],0.0064780191678524
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12372,132,1.09 [0.86-1.37],0.4732293891942268
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17362,676,1.08 [0.97-1.19],0.1552442320059711
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,14121,1881,1.04 [0.97-1.10],0.2669301252845665
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19524,108,1.06 [0.82-1.36],0.6592887777846355
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20169,59,1.26 [0.90-1.76],0.1783819611333376
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16833,69,1.12 [0.81-1.53],0.4954376639753862
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17919,1155,1.07 [0.99-1.16],0.0825480157192922
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16853,89,1.01 [0.76-1.34],0.9298671870780482
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14034,1794,1.06 [0.99-1.13],0.0768573656455433
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,18002,103,0.91 [0.70-1.19],0.4823323589945381
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16793,29,0.87 [0.53-1.44],0.5902516304487971
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16855,169,0.90 [0.74-1.11],0.3301701827469487
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17348,584,1.01 [0.91-1.13],0.8022435603075948
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19844,428,1.15 [1.02-1.31],0.027621550267749
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17238,552,0.98 [0.88-1.10],0.7351004667033272
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20044,465,1.12 [1.00-1.27],0.0588051489819755
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20155,58,1.67 [1.21-2.32],0.0019732579394762
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16905,141,0.94 [0.75-1.18],0.6006977547693091
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15733,746,1.04 [0.95-1.15],0.3946165851906541
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17315,551,1.03 [0.92-1.15],0.5998660078280569
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17010,246,0.79 [0.67-0.95],0.0097240827317844
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12306,66,1.22 [0.89-1.68],0.2213056391389104
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14937,2697,1.09 [1.04-1.15],0.0009680829248827
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12953,713,1.03 [0.93-1.14],0.5321675129727845
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19735,319,1.11 [0.96-1.29],0.1514754178480609
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20129,63,1.08 [0.78-1.51],0.6398835131197547
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17886,59,1.06 [0.75-1.49],0.7542001812154268
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12300,60,1.25 [0.89-1.74],0.2009073694861584
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16779,93,1.05 [0.80-1.37],0.746297734250107
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12718,478,1.14 [1.01-1.28],0.032155752954083
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17058,294,1.02 [0.87-1.19],0.8017457961137125
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16929,243,1.22 [1.03-1.44],0.0204257991090507
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16910,224,1.06 [0.89-1.26],0.52230557344221
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,14233,60,1.36 [0.98-1.90],0.0657512052990925
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20159,62,1.51 [1.09-2.07],0.011968409732695
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17244,480,1.04 [0.92-1.17],0.5592251322422677
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],19504,88,1.30 [0.99-1.71],0.0571626756902937
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19041,2277,1.03 [0.97-1.08],0.3647556263599689
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16894,130,1.01 [0.80-1.28],0.9149992683188192
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17274,588,1.06 [0.95-1.18],0.3143986438841932
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18966,231,0.90 [0.76-1.08],0.2649928373560252
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16889,203,1.12 [0.93-1.34],0.244604533765645
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18366,1680,1.03 [0.97-1.10],0.367854616403547
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17779,1093,1.05 [0.97-1.14],0.2379300870728051
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16814,50,0.90 [0.62-1.32],0.5929203060575541
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19527,111,1.01 [0.78-1.29],0.9594960684852956
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16911,147,1.06 [0.85-1.31],0.6165028663298262
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16847,83,1.02 [0.77-1.36],0.8849964247639724
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12304,64,1.20 [0.87-1.67],0.2678933017913337
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19028,1840,0.99 [0.93-1.05],0.7365664333808362
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),8124,22,1.23 [0.71-2.13],0.4576122863452806
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10314,28,1.30 [0.80-2.10],0.2920489120648162
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19898,266,1.12 [0.95-1.31],0.1734633279318589
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19722,90,1.07 [0.81-1.41],0.6553404915280933
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18949,1761,0.96 [0.90-1.02],0.1822363726225496
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19989,91,0.87 [0.66-1.15],0.3338079426162068
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19944,341,1.05 [0.91-1.21],0.5125903226751527
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Cystitis,16941,256,1.06 [0.90-1.25],0.4665965142300636
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Dialysis,17259,71,1.34 [0.99-1.81],0.0617870900059329
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8842,1838,0.99 [0.93-1.05],0.6930498771865243
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10397,111,1.11 [0.87-1.42],0.4103800799741152
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Endometriosis,8136,34,1.18 [0.76-1.84],0.4628150753544695
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8598,496,1.06 [0.94-1.19],0.3444505858949614
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16660,5348,0.99 [0.95-1.03],0.5552098909752975
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19968,70,1.03 [0.75-1.41],0.8476666187300705
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Hydrocele,7108,104,0.88 [0.68-1.15],0.363024258449123
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17215,283,1.07 [0.91-1.25],0.4306280406280948
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8566,1562,0.98 [0.91-1.05],0.5011116415166215
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10454,140,1.05 [0.84-1.31],0.6679338872608866
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),7110,106,0.82 [0.63-1.07],0.1459777111002863
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16756,71,1.05 [0.77-1.44],0.7580551750902883
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8995,893,0.98 [0.90-1.07],0.7068719777052734
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7058,54,0.83 [0.57-1.20],0.3161526932430909
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,8136,34,0.87 [0.55-1.36],0.5311725408774937
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20170,73,1.12 [0.82-1.52],0.4715590776885833
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20163,74,0.89 [0.65-1.22],0.4655567211531614
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19147,2462,0.96 [0.91-1.01],0.1466051401734527
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17494,809,0.93 [0.85-1.03],0.1518483840063111
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10332,46,0.99 [0.68-1.46],0.9746609109464636
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20111,508,1.06 [0.95-1.20],0.2987987313282955
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,7130,126,1.10 [0.87-1.40],0.4103289193035109
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,7140,136,1.05 [0.84-1.32],0.6690083615784073
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,7135,131,0.94 [0.74-1.19],0.5873053201341831
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20145,71,1.07 [0.78-1.46],0.6908486883126608
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18606,1921,0.98 [0.93-1.04],0.588208669060464
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10387,73,1.01 [0.75-1.38],0.9267774168253324
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8166,64,1.18 [0.85-1.63],0.3206992952832193
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8238,136,0.93 [0.74-1.16],0.5179188632989183
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8151,49,0.81 [0.55-1.19],0.2832779655403404
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8189,87,0.98 [0.74-1.30],0.8804591254274389
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17266,334,1.03 [0.89-1.19],0.6532292333529888
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19766,163,1.12 [0.91-1.37],0.2868996997922147
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8206,104,1.02 [0.79-1.32],0.8930774665492309
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,8124,22,0.83 [0.47-1.48],0.530121251544365
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8291,189,0.96 [0.79-1.16],0.6775877479267638
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8184,82,1.06 [0.80-1.42],0.6792594419391693
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8288,186,0.90 [0.74-1.09],0.2820972762639309
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19944,46,0.93 [0.62-1.39],0.7208809258179607
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",7135,131,0.80 [0.63-1.02],0.0694779598962889
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19964,3032,0.98 [0.94-1.03],0.5011190033071471
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17008,76,0.98 [0.72-1.33],0.9083507836993748
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17330,142,1.02 [0.82-1.28],0.8327597641423633
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19665,33,0.85 [0.53-1.36],0.4879980614879008
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16914,229,0.99 [0.83-1.18],0.92182120254871
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19975,343,1.09 [0.95-1.26],0.2229967217247036
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Uterine polyps,8136,34,1.09 [0.70-1.71],0.6924284017621777
